关注
Nalan Yurtsever
Nalan Yurtsever
Yale School of Medicine Department of Laboratory Medicine
在 yale.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Utility of TRPS-1 immunohistochemistry in diagnosis of metastatic breast carcinoma in cytology specimens
M Abdelwahed, N Yurtsever, D Savant, P Karam, C Gimenez, K Das, ...
Journal of the American Society of Cytopathology 11 (6), 345-351, 2022
162022
Prognostic factors associated with COVID-19 related severity in sickle cell disease
N Yurtsever, V Nandi, Y Ziemba, PA Shi
Blood Cells, Molecules, and Diseases 92, 102627, 2021
92021
Is Adenoidectomy and/or Tonsillectomy a Risk Factor for Allergic Diseases and Asthma in Adulthood?
N Yurtsever, S Soyyigit, ZC Sozener, D Mungan, SK Kose, Z Misirligil
The Eurasian Journal of Medicine 50 (3), 152, 2018
72018
Epidermal inclusion cyst in male breast: how to differentiate from other male breast lesions
M Ak, C Yurtsever, OF Cakir, N Yurtsever
Radiology Case Reports 17 (10), 3919-3922, 2022
22022
Exophiala dermatitidis isolated from blood in patient with steroid use
N Yurtsever, P Dougherty, S Condon, R Orsini, M Berman, GJ Berry, ...
American Journal of Clinical Pathology 154, S154-S155, 2020
12020
Anti-IH Related Hemolytic Reaction in a Sickle Cell Patient and Further Management While Avoiding Transfusion
N Yurtsever, K Wilson-Sandberg, J Dikeman, J Louie, K Fomani
American Journal of Clinical Pathology 154 (Supplement_1), S165-S166, 2020
12020
Therapeutic plasma exchange for hyperviscosity syndrome in IgA multiple myeloma
N Yurtsever, TC Binns, JE Hendrickson, CA Tormey, ES Lee
Laboratory Medicine 56 (1), 85-88, 2025
2025
Post‐exchange neutrophil count, but not post‐hematocrit, predicts endogenous erythropoiesis in patients with sickle cell disease undergoing chronic red cell exchange
N Yurtsever, N Tong, S Geetha, V Nandi, PA Shi
Transfusion 64 (12), 2270-2278, 2024
2024
Prophylactic Red Cell Exchange: Preventing Complications in Pregnant Patients with Sickle Cell Disease
N Sariipek, E Horstman, C Tormey, N Yurtsever
Blood 144, 5340, 2024
2024
Mixed-field ABO front typing as an early sign of disease recurrence in ABO-matched stem cell transplantation
N Yurtsever, ES Lee, L Pinatti, B Shah, CA Tormey, AJ Siddon
Immunohematology 40 (3), 89-92, 2024
2024
Lost in the Ds: Unexplained Loss of Rh (D) Antigen Expression By Serological Testing In Two Patients
G Carmichael, ES Lee, C Tormey, N Yurtsever, B Shah, L Bizzario
American Journal of Clinical Pathology 162 (Supplement_1), S148-S148, 2024
2024
Flow cytometry for RBC damage and complement activation
CF Villalba, N Yurtsever, K Paternoster, P Gallipoli, B Nash, L Bizzario, ...
American Journal of Clinical Pathology 162 (Supplement_1), S182-S183, 2024
2024
Hematocrits of red blood cell units increase during storage due to changes in mean corpuscular volume, impacting outcomes of red cell exchange procedures
E Lee, K Musante, J Errico, H Rinder, S Kleinstein, C Tormey, N Yurtsever
American Journal of Clinical Pathology 162 (Supplement_1), S157-S157, 2024
2024
Evaluating RhD Assessment By Automated Methodology: A Potential ‘Blind Spot’For RhD Variant Identification
N Yurtsever, C Tormey, L Bizzario, E Lee
American Journal of Clinical Pathology 162 (Supplement_1), S163-S163, 2024
2024
A multi‐institutional survey of apheresis services among institutions in the United States
N Yurtsever, JW Jacobs, GS Booth, J Schwartz, YA Park, JS Woo, D Lauro, ...
Journal of Clinical Apheresis 39 (4), e22138, 2024
2024
Heidenhain variant of Creutzfeldt-Jakob disease masquerading as neuromyelitis optica spectrum disorder: recognizing when apheresis is not the answer
O Burke, JW Jacobs, CA Tormey, HM Rinder, CA Figueroa Villalba, ...
Laboratory Medicine 55 (4), 520-523, 2024
2024
P‐IT‐6| Development of an Efficient, Automated Data Analytics Platform by Integration of Relational Databases
N Yurtsever, J Zenker, Y Jacobs, J Martone, S Sherwani, A Indrikovs, ...
Transfusion 63, 205A-206A, 2023
2023
Computational cohort discovery and coordinator-led validation to navigate potential research candidates to clinical trials
Y Ziemba, K Parnahay, P Ward, N Yurtsever, S Fox, C Schleicher, ...
Cancer Research 83 (7_Supplement), 3150-3150, 2023
2023
The need for structured pathology data in matching human subjects to cancer clinical trial criteria: A methodological approach
N Yurtsever, Y Ziemba, DA King, DJ Cooper, S Garza, CB Schleicher, ...
Cancer Research 83 (7_Supplement), 3167-3167, 2023
2023
Feasibility analysis of querying EHR databases for cancer clinical trial criteria
DJ Cooper, J Herman, N Yurtsever, S Garza, DA King, Y Ziemba
Cancer Research 83 (7_Supplement), 4394-4394, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20